Biotech Company Developing Treatments for Alzheimer's

(phase II trials)

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.
DONATE NOW

     
BioCrossroads' Indiana Seed Fund, Indiana's only targeted life sciences seed stage investment fund, has invested $300,000 in AgeneBio, an Indianapolis-based biotechnology start-up company focused on the development of therapeutic products for Alzheimer's disease, dementia and other memory disorders.  More than 5 million Americans suffer from Alzheimer's disease (AD), a number that is expected to grow exponentially over the next decade as a result of the aging population. Currently approved medications for AD treat only the clinical symptoms and have little impact on the progression of the disease. AgeneBio's research platform is based on intellectual property from Johns Hopkins University and has a number of new patents to broaden its approach to developing therapies. 
"AgeneBio's advancements in the treatment of memory-related conditions for the elderly could change the lives of millions of aging Americans and their families," said David Johnson, President and CEO of BioCrossroads. "The company's science is strong and the management team is comprised of seasoned executives from the pharmaceutical industry with highly applicable experience in the development and commercialization of drugs for psychiatric and neurological disorders." This is the tenth life sciences start up that has received funding from our Indiana Seed Fund.  Our fund has become a critical resource for Indiana's new companies holding great promise for the future of Indiana's economy and encouraging breakthrough innovation from Indiana's outstanding research community," continued Johnson. Read more: rehabpub.com

TODAY'S PHOTO

 

Immediate effects of chocolate on experimentally induced mood

The present studies demonstrate that eating a small amount of sweet food improves an experimentally induced negative mood state immediately and selectively and that this effect of chocolate is due to palatability. It is hypothesized that immediate mood effects of palatable food contribute to the habit of eating to cope with stress. Read more: sciencedirect.com

Беларусь ТВ

Posted YVN (AMYLOID @ PHOTO)